Tiltan Pharma

Technology 📍 Jerusalem, Israel 👥 1-10 employees 💰 $1.5M raised 📅 Founded 2006

One of the major advances in cancer research over the past decade has been the realization that tumor growth is dependent on the tumor's ability to recruit blood vessels from the neighboring tissue. Angiogenesis, the process by which new blood vessels are formed, is a hallmark capability of cancer, critical for the dev

🌐 Website in LinkedIn ← All Companies

📊 Company Overview

Sector

Technology

Country

Israel

Employees

1-10

Total Raised · Venture

$1.5M

Founded

2006

Cloud

Unknown

Email

Google Workspace

☁️ Cloud Infrastructure

🔒 Subscribers only Cloud Provider

Workspace	Google Workspace
CDN	🔒 Subscribers only

Detected via DNS records and HTTP response headers as of 2026-06-13.

💰 Estimated Cloud Spend

$36K – $90K / year across cloud providers

🛠 Tech Stack & Marketing

Ad Platforms	🔒 Subscribers only
Analytics & CRM	🔒 Subscribers only
CMS / Platform	Joomla
Frontend Stack	🔒 Subscribers only

Detected from Tiltan Pharma's public homepage as of 2026-06-13.

🔍 Compare with Similar Companies

Same sector (Technology), similar size

1-10 ☁️ Vercel

FleetCor Technologies

1-10 ☁️ Unknown

11-50 ☁️ Unknown

Data detected 2026-06-13 · Methodology · Suggest a correction